In animal models, HS‐10352 markedly suppressed the growth of transplanted tumors in a dose‐dependent manner in mice bearing gastric cancer HGC‐27 (PIK3CA E542K) and human breast cancer HCC‐1954 (PIK3CA H1047R) tumors. Here, PIK3CA is linked to breast carcinoma.